Status: Recruiting
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
The overall objective of this study is to determine the safety and efficacy of AAV2-hAADC delivered to the substantia nigra pars compacta (SNc) and ventral tegmental area (VTA) in children with aromatic L-amino acid decarboxylase (AADC) deficiency.
Participants needed: 42
Trial details
Phase: Phase 1Age: 24+Biological sex: AllType: InterventionalSponsor: Krzysztof BankiewiczUpdated: Aug 27, 2026Locations: 3
Eligibility criteria
Definite diagnosis of AADC deficiency, confirmed by at least two of the followin... [+8]
Intracranial neoplasm or any structural brain abnormality or lesion (e.g., sever... [+6]